Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-11-013167)

Filing Details

Accession Number:: 0001127602-11-013167
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-04-19 10:38:48
Reporting Period:: 2011-04-15

Filing Date:: 2011-04-19
Accepted Time:: 2011-04-19 10:38:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
912183	Cubist Pharmaceuticals Inc	CBST	Pharmaceutical Preparations (2834)	223192085

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219023	J W David Mcgirr	65 Hayden Avenue Lexington MA 02421	Svp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-04-15	25,000	$9.98	38,870	No	4	M	Direct
Common Stock	Disposition	2011-04-15	25,000	$32.00	13,870	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2011-04-15	25,000	$0.00	25,000	$9.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000	2003-03-02	2012-12-02	No	4	M	Direct

Footnotes

Sold pursuant to a Rule 10(b)5-1 Plan
This transaction was executed in multiple trades at prices randing from $31.95 to $32.13. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.